Phase 2 Study of Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma
Recruiting Phase 1,Phase 2 NCT06741020
Study Description
A Study Evaluating the Combination of Chemotherapy and Immunotherapy Delivered Directly to the Liver for Patients with Liver Cancer
Study Details
- Registry ID:
- NCT06741020
- Conditions:
- Hepatocellular Carcinoma (HCC)
- Phase:
- Phase 1,Phase 2
- Target Enrollment:
- 10 participants
- Start Date:
- Age Range:
- 18–75 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.